Back to results
US 2024/0197713 A1Published application
Lfa-1 antagonists for treating inflammatory bowel diesease
AssigneeVivaVision Biotech, Inc.
InventorsWang Shen, Junhong Shi, Jianming Zhu, Bitian Yan, Dong Wei, Kuifeng Dang, Yue Ding
Life of this patent
Estimating the term…
Abstract
Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of an inflammatory bowel disease with a lymphocyte function-associated antigen-1 antagonist.
Claims26
A method of treating, preventing, or ameliorating one or more symptoms of an inflammatory bowel disease in a subject, comprising administering to the subject in need thereof a therapeutically effective amount of an LFA-1 antagonist.
24-26. (canceled)
(canceled)
Dependencies are inferred from the claim text.